Matrix-M with RH5.2 VLP and/or R21
1 treatment and condition followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Matrix-M with RH5.2 VLP and/or R21 for malaria, falciparum | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |